Terms: = Head and neck cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Prognosis
868 results:
1. Identification of AURKA as a Biomarker Associated with Cuproptosis and Ferroptosis in HNSCC.
Jia X; Tian J; Fu Y; Wang Y; Yang Y; Zhang M; Yang C; Liu Y
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673957
[TBL] [Abstract] [Full Text] [Related]
2. CDK1 and CCNA2 play important roles in oral squamous cell carcinoma.
Zhang J; Di Y; Zhang B; Li T; Li D; Zhang H
Medicine (Baltimore); 2024 Apr; 103(16):e37831. PubMed ID: 38640322
[TBL] [Abstract] [Full Text] [Related]
3. Identification of two distinct head and neck squamous cell carcinoma subtypes based on fatty acid metabolism-related signatures: Implications for immunotherapy and chemotherapy.
Zou J; Dai Y; Xu G; Kai Y; Lan L; Zhang J; Wang Y
Medicine (Baltimore); 2024 Apr; 103(16):e37824. PubMed ID: 38640298
[TBL] [Abstract] [Full Text] [Related]
4. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
[TBL] [Abstract] [Full Text] [Related]
5. [Phase Ⅱ clinical trial of PD-1 inhibitor combined with chemotherapy for locally advanced resectable oral squamous cell carcinoma].
Wang HL; Yue K; Wu YS; Duan YS; Jing C; Wang XD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):335-342. PubMed ID: 38599641
[No Abstract] [Full Text] [Related]
6. Comprehensive bioinformatics analysis unveils THEMIS2 as a carcinogenic indicator related to immune infiltration and prognosis of thyroid cancer.
Liu JF; Zou B; Xiang C; Yan HC
Sci Rep; 2024 Apr; 14(1):8156. PubMed ID: 38589421
[TBL] [Abstract] [Full Text] [Related]
7. Prediction of malignant esophageal fistula in esophageal cancer using a radiomics-clinical nomogram.
Zhu C; Sun W; Chen C; Qiu Q; Wang S; Song Y; Ma X
Eur J Med Res; 2024 Apr; 29(1):217. PubMed ID: 38570887
[TBL] [Abstract] [Full Text] [Related]
8. Development and validation of a nomogram model for predicting distant metastasis of aged ≥50 patients with thyroid carcinoma: a SEER database analysis.
Yu JW; Pang R; Liu B; Zhang L; Kong LY
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2351-2362. PubMed ID: 38567598
[TBL] [Abstract] [Full Text] [Related]
9. STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance.
Li T; Zhang W; Niu M; Wu Y; Deng X; Zhou J
Front Immunol; 2024; 15():1342647. PubMed ID: 38550593
[TBL] [Abstract] [Full Text] [Related]
10. Development and internal validation of a nomogram based on peripheral blood inflammatory markers for predicting prognosis in nasopharyngeal carcinoma.
Lai J; Lin P; Zhuang J; Xie Z; Zhou H; Yang D; Chen Z; Jiang D; Huang J
Cancer Med; 2024 Apr; 13(7):e7135. PubMed ID: 38549496
[TBL] [Abstract] [Full Text] [Related]
11. An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers.
Xirou V; Moutafi M; Bai Y; Nwe Aung T; Burela S; Liu M; Kimple RJ; Shabbir Ahmed F; Schultz B; Flieder D; Connolly DC; Psyrri A; Burtness B; Rimm DL
Oral Oncol; 2024 May; 152():106750. PubMed ID: 38547779
[TBL] [Abstract] [Full Text] [Related]
12. Deciphering a Prognostic Signature Based on Soluble Mediators Defines the Immune Landscape and Predicts prognosis in HNSCC.
Chi H; Peng G; Song G; Zhang J; Xie X; Yang J; Xu J; Zhang J; Xu K; Wu Q; Yang G
Front Biosci (Landmark Ed); 2024 Mar; 29(3):130. PubMed ID: 38538268
[TBL] [Abstract] [Full Text] [Related]
13. M6A-mediated molecular patterns and tumor microenvironment infiltration characterization in nasopharyngeal carcinoma.
Wang Y; Peng L; Wang F
Cancer Biol Ther; 2024 Dec; 25(1):2333590. PubMed ID: 38532632
[TBL] [Abstract] [Full Text] [Related]
14. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
[TBL] [Abstract] [Full Text] [Related]
15. Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration.
Nakayama I; Ohashi M; Nunobe S
Chin Clin Oncol; 2024 Feb; 13(1):8. PubMed ID: 38453658
[TBL] [Abstract] [Full Text] [Related]
16. Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma.
Gong H; Liu Z; Yuan C; Luo Y; Chen Y; Zhang J; Cui Y; Zeng B; Liu J; Li H; Deng Z
Comput Biol Med; 2024 Mar; 171():108198. PubMed ID: 38417385
[TBL] [Abstract] [Full Text] [Related]
17. SLC20A1 is a prospective prognostic and therapy response predictive biomarker in head and neck squamous cell carcinoma.
Qian X; Jin M; Bei Y; Zhou C; Fang S; Liu K
Aging (Albany NY); 2024 Feb; 16(5):4423-4444. PubMed ID: 38412319
[TBL] [Abstract] [Full Text] [Related]
18. Molecular subtype identification and prognosis stratification based on golgi apparatus-related genes in head and neck squamous cell carcinoma.
Zhang A; He X; Zhang C; Tang X
BMC Med Genomics; 2024 Feb; 17(1):53. PubMed ID: 38365684
[TBL] [Abstract] [Full Text] [Related]
19. Neuronal CFL1 upregulation in head and neck squamous cell carcinoma enhances tumor-nerve crosstalk and promotes tumor growth.
Liu R; Wang C; Sun Z; Shi X; Zhang Z; Luo J
Mol Carcinog; 2024 May; 63(5):874-884. PubMed ID: 38353363
[TBL] [Abstract] [Full Text] [Related]
20. An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients.
Chen B; Han Y; Sheng S; Deng J; Vasquez E; Yau V; Meng M; Sun C; Wang T; Wang Y; Sheng M; Wu T; Wang X; Liu Y; Lin N; Zhang L; Shao W
J Cancer Res Clin Oncol; 2024 Feb; 150(2):91. PubMed ID: 38347320
[TBL] [Abstract] [Full Text] [Related]
[Next]
